Zurich Insurance Group Ltd FI boosted its holdings in Zoetis Inc (NYSE:ZTS) by 154.9% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 159,481 shares of the company’s stock after acquiring an additional 96,913 shares during the period. Zurich Insurance Group Ltd FI’s holdings in Zoetis were worth $18,099,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also modified their holdings of ZTS. Paloma Partners Management Co purchased a new position in shares of Zoetis during the 2nd quarter worth about $2,264,000. Capital Bank & Trust Co lifted its holdings in shares of Zoetis by 1,997.1% during the 2nd quarter. Capital Bank & Trust Co now owns 1,468 shares of the company’s stock worth $167,000 after acquiring an additional 1,398 shares during the period. Zebra Capital Management LLC purchased a new position in shares of Zoetis during the 2nd quarter worth about $211,000. Vanguard Group Inc. lifted its holdings in shares of Zoetis by 1.0% during the 2nd quarter. Vanguard Group Inc. now owns 36,765,577 shares of the company’s stock worth $4,172,526,000 after acquiring an additional 346,167 shares during the period. Finally, VisionPoint Advisory Group LLC purchased a new position in shares of Zoetis during the 2nd quarter worth about $245,000. 90.09% of the stock is currently owned by hedge funds and other institutional investors.
Several research analysts recently commented on ZTS shares. Cantor Fitzgerald restated an “overweight” rating and issued a $130.00 price target (up previously from $116.00) on shares of Zoetis in a report on Wednesday, June 12th. Guggenheim started coverage on shares of Zoetis in a report on Thursday, May 23rd. They issued a “buy” rating and a $114.00 price target on the stock. Argus set a $140.00 price target on shares of Zoetis and gave the company a “buy” rating in a report on Wednesday, September 4th. Stifel Nicolaus set a $140.00 price target on shares of Zoetis and gave the company a “buy” rating in a report on Friday, September 13th. Finally, Goldman Sachs Group started coverage on shares of Zoetis in a report on Monday, September 9th. They issued a “conviction-buy” rating and a $145.00 price target on the stock. Seven analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. Zoetis has an average rating of “Buy” and an average target price of $120.94.
NYSE ZTS traded up $0.83 during mid-day trading on Friday, hitting $125.10. The company’s stock had a trading volume of 133,736 shares, compared to its average volume of 2,059,244. Zoetis Inc has a 52-week low of $78.90 and a 52-week high of $130.08. The stock’s fifty day simple moving average is $123.64 and its two-hundred day simple moving average is $109.75. The company has a debt-to-equity ratio of 2.74, a current ratio of 4.17 and a quick ratio of 2.87. The firm has a market capitalization of $59.97 billion, a P/E ratio of 39.98, a price-to-earnings-growth ratio of 3.09 and a beta of 0.87.
Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.82 by $0.08. The company had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.51 billion. Zoetis had a net margin of 22.74% and a return on equity of 72.86%. The business’s quarterly revenue was up 9.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.77 earnings per share. On average, equities analysts forecast that Zoetis Inc will post 3.57 earnings per share for the current fiscal year.
Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.
Further Reading: Options Trading – What is a Straddle?
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.